Why Are Shares of Merck Up Today?

benzinga.com/trading-ideas/movers/25/11/49014786/why-are-shares-of-merck-up-today

Shares of Merck & Company, Inc. (NASDAQ:MRK) are trading higher the FDA approved pembrolizumab with enfortumab vedotin-ejfv for muscle-invasive bladder cancer.
MRK shares are powering higher on strong volume. Follow the breaking news ...
Full story available on Benzinga.com

This story appeared on benzinga.com, 2025-11-21 20:07:01.
The Entire Business World on a Single Page. Free to Use →